What Happened?
, -based Bicara Therapeutics Appointed David Raben as CMO, Bicara Therapeutics
About the Company
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company`s dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy.
About the Person
David Raben is CMO, Bicara Therapeutics at Bicara Therapeutics. Previously, David held various senior HR leadership roles in the industry.
Info Source
News
Short Profile